NCT02441322
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
- Locations
-
- University Of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Neuroectodermal Tumors
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
6,011 public trials
1,222 recruiting studies
Neuroectodermal Tumors trial results
NCT01873248
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
- Locations
-
- University of California Los Angeles, Nuclear Medicine Clinic of the Department of Molecular and Medical Pharmacology Los Angeles, California, United States
NCT03101254
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Completed
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
NCT01817751
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
- Locations
-
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
NCT04364230
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +16 more
- Locations
-
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
- University of Virginia Charlottesville, Virginia, United States
NCT01894672
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States
NCT01798004
- Conditions
- Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +15 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
Completed
A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
NCT02549937
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +12 more
- Locations
-
- City of Hope Comprehensive Cancer Center Los Angeles, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- SCRI at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
NCT01585194
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01856920
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- NIH Clinical Center Bethesda, Maryland, United States